Safety and efficacy of apixaban and rivaroxaban in obese patients with acute venous thrombosis/embolism

被引：2
作者：
Anusim, Nwabundo [1 ]
Ghimire, Bipin [1 ]
Smalley, Melanie [1 ]
Jaiyesimi, Ishmael [1 ]
Gaikazian, Susanna [1 ]
机构：
[1] Beaumont Hlth, Dept Hematol & Oncol, 3601 W 13 Mile Rd, Royal Oak, MI 48073 USA
来源：
EUROPEAN JOURNAL OF HAEMATOLOGY | 2022年 / 109卷 / 04期
关键词：
DIRECT ORAL ANTICOAGULANTS; WARFARIN;
D O I：
10.1111/ejh.13817
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：409 / 412
页数：4
相关论文
共 15 条
  • [1] Oral Apixaban for the Treatment of Acute Venous Thromboembolism
    Agnelli, Giancarlo
    Buller, Harry R.
    Cohen, Alexander
    Curto, Madelyn
    Gallus, Alexander S.
    Johnson, Margot
    Masiukiewicz, Urszula
    Pak, Raphael
    Thompson, John
    Raskob, Gary E.
    Weitz, Jeffrey I.
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2013, 369 (09) : 799 - 808
  • [2] Oral Rivaroxaban for Symptomatic Venous Thromboembolism.
    Bauersachs, Rupert
    Berkowitz, Scott D.
    Brenner, Benjamin
    Buller, Harry R.
    Decousus, Herve
    Gallus, Alex S.
    Lensing, Anthonie W.
    Misselwitz, Frank
    Prins, Martin H.
    Raskob, Gary E.
    Segers, Annelise
    Verhamme, Peter
    Wells, Phil
    Agnelli, Giancarlo
    Bounameaux, Henri
    Cohen, Alexander
    Davidson, Bruce L.
    Piovella, Franco
    Schellong, Sebastian
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2010, 363 (26) : 2499 - 2510
  • [3] Edoxaban versus Warfarin for the Treatment of Symptomatic Venous Thromboembolism
    Bueller, Harry R.
    Decousus, Herve
    Grosso, Michael A.
    Mercuri, Michele
    Middeldorp, Saskia
    Prins, Martin H.
    Raskob, Gary E.
    Schellong, Sebastian M.
    Schwocho, Lee
    Segers, Annelise
    Shi, Minggao
    Verhamme, Peter
    Wells, Phil
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2013, 369 (15) : 1406 - 1415
  • [4] Effectiveness and Safety of Direct Oral Anticoagulants versus Warfarin in Obese Patients with Acute Venous Thromboembolism
    Coons, James C.
    Albert, Lauren
    Bejjani, Andrea
    Iasella, Carlo J.
    [J]. PHARMACOTHERAPY, 2020, 40 (03): : 204 - 210
  • [5] Obesity and thrombosis
    Darvall, K. A. L.
    Sam, R. C.
    Silverman, S. H.
    Bradbury, A. W.
    Adam, D. J.
    [J]. EUROPEAN JOURNAL OF VASCULAR AND ENDOVASCULAR SURGERY, 2007, 33 (02) : 223 - 233
  • [6] Martins K, 2016, J SENSORS, V2016, DOI [10.1155/2016/7965431, 10.1111/jth.13323]
  • [7] A single center retrospective cohort study evaluating use of direct oral anticoagulants (DOACs) in morbidly obese veteran population
    Patil, Tanvi
    Lebrecht, Morgan
    [J]. THROMBOSIS RESEARCH, 2020, 192 : 124 - 130
  • [8] Rivaroxaban Versus Warfarin for Stroke Prevention and Venous Thromboembolism Treatment in Extreme Obesity and High Body Weight
    Perales, Isaac J.
    San Agustin, Kimberly
    DeAngelo, Jessica
    Campbell, Ashley M.
    [J]. ANNALS OF PHARMACOTHERAPY, 2020, 54 (04) : 344 - 350
  • [9] Peak plasma concentration of direct oral anticoagulants in obese patients weighing over 120 kilograms: A retrospective study
    Piran, Siavash
    Traquair, Hugh
    Chan, Noel
    Bhagirath, Vinai
    Schulman, Sam
    [J]. RESEARCH AND PRACTICE IN THROMBOSIS AND HAEMOSTASIS, 2018, 2 (04) : 684 - 688
  • [10] Warfarin: almost 60 years old and still causing problems
    Pirmohamed, Munir
    [J]. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2006, 62 (05) : 509 - 511
12